Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $138.2M
Liabilities Breakdown FY2025
Total Liabilities: $94.0M
Asset Breakdown
Total Assets: $138.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.8M | 33.1% |
| Accounts Receivable | $157.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.6M | 5.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $84.6M | 61.2% |
Liabilities Breakdown
Total Liabilities: $94.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 1.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $92.3M | 98.2% |